Amit Gupta Sells 23,416 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLX) COO Amit Gupta sold 23,416 shares of Cardlytics stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $11.91, for a total transaction of $278,884.56. Following the transaction, the chief operating officer now owns 122,676 shares of the company’s stock, valued at $1,461,071.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Cardlytics Stock Down 6.9 %

NASDAQ CDLX traded down $0.85 during mid-day trading on Wednesday, reaching $11.52. The stock had a trading volume of 652,591 shares, compared to its average volume of 1,533,442. Cardlytics, Inc. has a 1 year low of $4.94 and a 1 year high of $20.52. The stock has a market cap of $554.96 million, a PE ratio of -3.33 and a beta of 1.44. The company has a fifty day moving average price of $11.10 and a 200 day moving average price of $9.64. The company has a debt-to-equity ratio of 1.91, a current ratio of 1.31 and a quick ratio of 1.31.

Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings data on Thursday, March 14th. The company reported ($0.14) earnings per share for the quarter. Cardlytics had a negative return on equity of 25.38% and a negative net margin of 43.56%. The firm had revenue of $89.17 million during the quarter.

Wall Street Analyst Weigh In

CDLX has been the subject of several recent research reports. Needham & Company LLC lifted their target price on shares of Cardlytics from $15.00 to $17.00 and gave the company a “buy” rating in a report on Tuesday, April 9th. Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “buy” rating and lifted their target price for the company from $10.00 to $18.00 in a report on Friday, March 15th. Finally, Lake Street Capital lifted their target price on shares of Cardlytics from $13.00 to $18.00 and gave the company a “buy” rating in a report on Friday, March 15th.

Institutional Investors Weigh In On Cardlytics

Hedge funds have recently added to or reduced their stakes in the stock. Tower Research Capital LLC TRC raised its stake in Cardlytics by 349.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 9,602 shares of the company’s stock valued at $88,000 after buying an additional 7,465 shares during the last quarter. D L Carlson Investment Group Inc. purchased a new stake in Cardlytics during the 3rd quarter valued at $173,000. New York State Common Retirement Fund raised its stake in Cardlytics by 600.8% during the 3rd quarter. New York State Common Retirement Fund now owns 13,498 shares of the company’s stock valued at $223,000 after buying an additional 11,572 shares during the last quarter. Shikiar Asset Management Inc. purchased a new stake in Cardlytics during the 3rd quarter valued at $247,000. Finally, SG Americas Securities LLC purchased a new stake in Cardlytics during the 3rd quarter valued at $264,000. 68.10% of the stock is currently owned by hedge funds and other institutional investors.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.